Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anika Kasprick

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Autoimmunity Reviews|April 28, 2015
Revisiting the role of mast cells in autoimmunityXinhua Yu, Anika Kasprick, Frank Petersen
Current Protocols in Pharmacology|February 21, 2019
Drug Discovery for Pemphigoid DiseasesAnika Kasprick, Katja Bieber, Ralf J Ludwig
Frontiers in Immunology|March 16, 2018
The Role of Mast Cells in Autoimmune Bullous DermatosesXinhua Yu, Anika Kasprick, Karin Hartmann, et al.
British Journal of Pharmacology|January 25, 2020
Treatment with anti-neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in miceAnika Kasprick, Maxi Hofrichter, Bryan Smith, et al.
European Journal of Immunology|February 14, 2015
Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisitaAnika Kasprick, Xinhua Yu, Julia Scholten, et al.
Frontiers in Immunology|July 28, 2018
Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa AcquisitaHiroshi Koga, Anika Kasprick, Rosa López, et al.
Biomedicines|November 27, 2024
Dexamethasone's Clinical Efficacy in Experimental Autoimmune Pancreatitis Correlates with a Unique Transcriptomic Signature, Whilst Kinase Inhibitors Are Not EffectiveOttavia Agrifoglio, Anika Kasprick, Natalie Gross, et al.
The Journal of Investigative Dermatology|July 9, 2016
PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa AcquisitaHiroshi Koga, Andreas Recke, Gestur Vidarsson, et al.
Scientific Reports|December 6, 2016
T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisitaKatja Bieber, Mareike Witte, Shijie Sun, et al.
The Journal of Investigative Dermatology|November 18, 2021
Multiple Modes of Action Mediate the Therapeutic Effect of Intravenous IgG in Experimental Epidermolysis Bullosa AcquisitaElena Pipi, Anika Kasprick, Hiroaki Iwata, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Autoimmunity Reviews|April 28, 2015
Revisiting the role of mast cells in autoimmunityXinhua Yu, Anika Kasprick, Frank Petersen
Current Protocols in Pharmacology|February 21, 2019
Drug Discovery for Pemphigoid DiseasesAnika Kasprick, Katja Bieber, Ralf J Ludwig
Frontiers in Immunology|March 16, 2018
The Role of Mast Cells in Autoimmune Bullous DermatosesXinhua Yu, Anika Kasprick, Karin Hartmann, et al.
British Journal of Pharmacology|January 25, 2020
Treatment with anti-neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in miceAnika Kasprick, Maxi Hofrichter, Bryan Smith, et al.
European Journal of Immunology|February 14, 2015
Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisitaAnika Kasprick, Xinhua Yu, Julia Scholten, et al.
Frontiers in Immunology|July 28, 2018
Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa AcquisitaHiroshi Koga, Anika Kasprick, Rosa López, et al.
Biomedicines|November 27, 2024
Dexamethasone's Clinical Efficacy in Experimental Autoimmune Pancreatitis Correlates with a Unique Transcriptomic Signature, Whilst Kinase Inhibitors Are Not EffectiveOttavia Agrifoglio, Anika Kasprick, Natalie Gross, et al.
The Journal of Investigative Dermatology|July 9, 2016
PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa AcquisitaHiroshi Koga, Andreas Recke, Gestur Vidarsson, et al.
Scientific Reports|December 6, 2016
T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisitaKatja Bieber, Mareike Witte, Shijie Sun, et al.
The Journal of Investigative Dermatology|November 18, 2021
Multiple Modes of Action Mediate the Therapeutic Effect of Intravenous IgG in Experimental Epidermolysis Bullosa AcquisitaElena Pipi, Anika Kasprick, Hiroaki Iwata, et al.
Pageof 3